Kato, Hidekazu
Kimura, Hiroki
Kushima, Itaru http://orcid.org/0000-0002-0018-5178
Takahashi, Nagahide
Aleksic, Branko http://orcid.org/0000-0001-8982-4580
Ozaki, Norio http://orcid.org/0000-0002-7360-4898
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21wm0425007, JP21dm0207075, JP21dk0307103, JP21ak0101113)
MEXT | Japan Society for the Promotion of Science (20K20602, 21H04815, 21H02848, 21K20866)
Article History
Received: 15 March 2022
Revised: 12 June 2022
Accepted: 20 June 2022
First Online: 12 July 2022
Competing interests
: HK, HK, IK, NT and BA declare no competing interest. NO has received research support or speakers’ honoraria from, or has served as a joint researcher with, or a consultant to, Sumitomo Dainippon, Eisai, Otsuka, KAITEKI, Mitsubishi Tanabe, Shionogi, Eli Lilly, Mochida, DAIICHI SANKYO, TSUMURA, Takeda, Meiji Seika Pharma, Kyowa, EA Pharma, Viatris, Kyowa Kirin, MSD, Janssen, Yoshitomi, Ricoh, Taisho, and Nippon Boehringer Ingelheim outside the submitted work.